Advertisement
Advertisement

SRTS

SRTS logo

Sensus Healthcare, Inc

5.06
USD
Sponsored
+0.22
+4.55%
Feb 06, 15:59 UTC -5
Closed
exchange

After-Market

5.07

+0.01
+0.10%

SRTS Earnings Reports

Positive Surprise Ratio

SRTS beat 24 of 37 last estimates.

65%

Next Report

Next Week
Date of Next Report
Feb 12, 2026
Estimate for Q4 25 (Revenue/ EPS)
$8.51M
/
-$0.07
Implied change from Q3 25 (Revenue/ EPS)
+23.65%
/
+16.67%
Implied change from Q4 24 (Revenue/ EPS)
-34.86%
/
-177.78%

Sensus Healthcare, Inc earnings per share and revenue

On Nov 06, 2025, SRTS reported earnings of -0.06 USD per share (EPS) for Q3 25, beating the estimate of -0.09 USD, resulting in a 38.08% surprise. Revenue reached 6.88 million, compared to an expected 6.44 million, with a 6.91% difference. The market reacted with a +19.32% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analysts forecast an EPS of -0.07 USD, with revenue projected to reach 8.51 million USD, implying an increase of 16.67% EPS, and increase of 23.65% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Mesa Laboratories Inc
Report Date
Feb 03, 2026 For Q3 26
Estimate
$0.28
Actual
$3.07
Surprise
+987.88%
logo
Accuray Incorporated
Report Date
Feb 04, 2026 For Q2 26
Estimate
-$0.11
Actual
-$0.11
Surprise
+1.96%
logo
Thermo Fisher Scientific, Inc.
Report Date
Jan 29, 2026 For Q4 25
Estimate
$6.51
Actual
$6.57
Surprise
+0.91%
logo
Idexx Laboratories Inc
Report Date
Feb 02, 2026 For Q4 25
Estimate
$2.98
Actual
$3.08
Surprise
+3.12%
logo
IQVIA Holdings Inc.
Report Date
Feb 05, 2026 For Q4 25
Estimate
$3.43
Actual
$3.42
Surprise
-0.34%
logo
Mettler-Toledo International
Report Date
Feb 05, 2026 For Q4 25
Estimate
$12.92
Actual
$13.36
Surprise
+3.34%
logo
STERIS plc
Report Date
Feb 04, 2026 For Q3 26
Estimate
$2.55
Actual
$2.52
Surprise
-0.99%
logo
Hologic Inc
Report Date
Jan 29, 2026 For Q1 26
Estimate
$1.11
Actual
$1.04
Surprise
-6.45%
FAQ
For Q3 2025, Sensus Healthcare, Inc reported EPS of -$0.06, beating estimates by 38.08%, and revenue of $6.88M, 6.91% above expectations.
The stock price moved up 19.32%, changed from $3.52 before the earnings release to $4.20 the day after.
The next earning report is scheduled for Feb 12, 2026.
Based on 5 analysts, Sensus Healthcare, Inc is expected to report EPS of -$0.07 and revenue of $8.51M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement